Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation

Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Vijay Ivaturi, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M. Zetola, Drew Weissman, Tawanda Gumbo, Gregory P. Bisson

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation'. Together they form a unique fingerprint.

Medicine & Life Sciences